BioVaxys Technology Corp. BVAXF

Primary Symbol: C.BIOV

BioVaxys Technology Corp. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on improving patient lives with novel immunotherapies based on the DPX immune-educating technology platform and its HapTenix neoantigen tumor cell construct platform, for treating cancers, infectious disease, antigen desensitization and other immunological fields. The Company's clinical-stage pipeline includes maveropepimut-S, which is in phase II clinical development for advanced Relapsed-Refractory Diffuse Large B Cell Lymphoma (DLBCL) and platinum resistant ovarian cancer, and BVX-0918, a personalized immunotherapeutic vaccine using its HapTenix neoantigen tumor cell construct platform for treating refractive late-stage ovarian cancer. The Company is also leveraging its expertise in tumor immunology by creating a unique library of T-lymphocytes and other datasets post-vaccination with its personalized immunotherapeutic vaccines to identify new targetable tumor antigens.

CSE:BIOV - Post by User

BioVaxys Technology Corp. > The train rode to higher ground is about to leave the train

<< Previous

Bullboard Posts

Next >>

Post by Mario79on Feb 02, 2024 1:12pm

137 Views

Post# 35859903

The train rode to higher ground is about to leave the train

We are 6.5 cents and bidding at 6 cents. This stock has s going gangbusyers on my opinion. It's going to halt anytime so better get in now before it's too late.

<< Previous

Bullboard Posts

Next >>

Gold vs. bitcoin, where should you invest?